Concepedia

Weiyuan Wang

WW

Statistics

Publications

33

Citations

927

H-Index

18

Active since

2010

Affiliations

Central South University(Current)

Second Xiangya Hospital of Central South University

Xiangya Hospital Central South University

Nanjing Normal University

Huaiyin Institute of Technology

Weiyuan Wang is an author at Central South University specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2010–2023

33

Publications

33

Activation of Akt/mTOR Pathway Is Associated with Poor Prognosis of Nasopharyngeal Carcinoma

Weiyuan Wang, Qiuyuan Wen, Lina Xu et al. · PLoS ONE · 2014 · 79 citations · Full text

, , +17

Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil

Junpu Wang, Wanming Hu, Kuansong Wang et al. · International Journal of Oncology · 2016 · 75 citations · Full text

, , +17

CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway

Qiuyuan Wen, Weiyuan Wang, Jiadi Luo et al. · Oncotarget · 2016 · 57 citations · Full text

, , +17

Suppression Of β-catenin Nuclear Translocation By CGP57380 Decelerates Poor Progression And Potentiates Radiation-Induced Apoptosis in Nasopharyngeal Carcinoma

Weiyuan Wang, Qiuyuan Wen, Jiadi Luo et al. · Theranostics · 2017 · 55 citations · Full text

, , +17

Exosome-mediated miR-7-5p delivery enhances the anticancer effect of Everolimus via blocking MNK/eIF4E axis in non-small cell lung cancer

Sile Liu, Weiyuan Wang, Yue Ning et al. · Cell Death and Disease · 2022 · 47 citations · Full text

, , +16

1–5 of 33